Exercise Training for Heart Disease
(EXCEED2 Trial)
Trial Summary
What is the purpose of this trial?
This study will compare the effects of two different types of training on exercise capacity in women with coronary heart disease (CHD). Participants will be randomized into either the virtual high-intensity interval training (HIIT) or the virtual moderate-to-vigorous intensity continuous training (MICT). After randomization, patients will exercise twice a week, for 12 weeks. The sessions will be conducted virtually. Patients will undergo a maximal exercise test, cardiometabolic indicators (height (cm), body mass (kg), body composition (%), waist circumference (cm) and, resting blood pressure) and complete questionnaires about quality of life, mental health, self-determined motivation, self-efficacy and enjoyment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Exercise Training, Cardiac Rehabilitation, Physical Therapy, Exercise Intervention for heart disease?
Research shows that regular exercise training can improve heart health by enhancing exercise tolerance, reducing stress on the heart, and improving quality of life for heart disease patients. Exercise is recommended as a key part of cardiac rehabilitation, helping to prevent further heart issues and improve overall cardiovascular health.12345
Is exercise training safe for people with heart disease?
How does exercise training differ from other treatments for heart disease?
Exercise training, as part of cardiac rehabilitation, is unique because it combines physical activity with behavioral and psychosocial interventions to improve heart function and quality of life. Unlike medications, it focuses on enhancing physical endurance, reducing symptoms, and improving psychological well-being through a personalized exercise regimen.1112131415
Research Team
Jennifer Reed, PhD
Principal Investigator
Ottawa Heart Institute Research Corporation
Eligibility Criteria
This trial is for women with coronary heart disease (CHD) who are interested in participating in a virtual exercise program. The study requires participants to train twice a week for 12 weeks, but specific inclusion and exclusion criteria details were not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized into either virtual HIIT or MICT and exercise twice a week for 12 weeks
Follow-up
Participants are monitored for changes in health measures and exercise capacity
Treatment Details
Interventions
- Exercise Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Heart Institute Research Corporation
Lead Sponsor